Character formulas for Kirillov-Reshetikhin modules via folding of supercharacters of gl ( M | N )
Nuclear Physics B · 2026-04 · 1025 · 117400
DOI: 10.1016/j.nuclphysb.2026.117400 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nuclear Physics B, 2026-04. Verfasst von Zengo Tsuboi. Die Arbeit nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Science and Higher Education of the Russian Federation, Far Eastern Federal University.
Abstract (Originalsprache)
We derive decomposition formulas for supercharacters of quantum affine ortho-symplectic superalgebras and twisted quantum affine superalgebras into supercharacters of their finite-type quantum sub-superalgebras, by employing Cauchy-type identities for supersymmetric Schur functions. These formulas are obtained via a folding (reduction) procedure applied to the supercharacters of the finite-dimensional general linear Lie superalgebra $\mathfrak{gl}(M|N)$. As a special case, our results provide explicit character formulas for a class of Kirillov--Reshetikhin modules of quantum affine algebras (and their Yangian counterparts), thereby proving a previously proposed conjecture derived from Bethe ansatz analysis (arXiv:2309.16660).
Förderung
- Ministry of Science and Higher Education of the Russian Federation
- Far Eastern Federal University
Zitieren
APA
Tsuboi, Z. (2026). Character formulas for Kirillov-Reshetikhin modules via folding of supercharacters of gl ( M | N ). Nuclear Physics B, 1025, 117400. https://doi.org/10.1016/j.nuclphysb.2026.117400
Vancouver
Tsuboi Z. Character formulas for Kirillov-Reshetikhin modules via folding of supercharacters of gl ( M | N ). Nuclear Physics B. 2026;1025:117400. doi:10.1016/j.nuclphysb.2026.117400
BibTeX
@article{Tsuboi2026,
author = {Tsuboi, Zengo},
title = {Character formulas for Kirillov-Reshetikhin modules via folding of supercharacters of gl ( M | N )},
journal = {Nuclear Physics B},
year = {2026},
volume = {1025},
pages = {117400},
doi = {10.1016/j.nuclphysb.2026.117400}
}
EUVIMED